Thoroughbred Financial Services, LLC Abiomed Inc Transaction History

Thoroughbred Financial Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$175.89 - $279.23 $175,890 - $279,230	-1,000 Closed	0 $0
Q2 2019 Jul 16, 2019	SELL	$250.96 - $284.94 $65.1 Million - $73.9 Million	-259,490 Reduced 99.62%	1,000 $0
Q2 2019 Jul 16, 2019	BUY	$250.96 - $284.94 $65.1 Million - $73.9 Million	259,352 Added 22790.16%	260,490 $0
Q1 2019 May 07, 2019	BUY	$276.39 - $362.25 $23,493 - $30,791	85 Added 8.07%	1,138 $325,000
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $295,977 - $467,795	1,053 New	1,053 $342,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.